Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

7 projects found matching your search criteria :

  1. Patient-specific iPS cells as a novel approach to study patophysiology of mTOR-related neurodevelopmental disorders

    Call: SONATA 6 , Panel: NZ3

    Principal investigator: dr Ewa Liszewska

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

  2. Inducible pluripotent stem cells as a tool in articular cartilage regeneration.

    Call: SONATA BIS 2 , Panel: NZ3

    Principal investigator: dr Wiktoria Suchorska

    Wielkopolskie Centrum Onkologii

  3. Identification of molecular mechanism underlying the phenotype development of Emery-Dreifuss muscular dystrophy.

    Call: SONATA 17 , Panel: NZ5

    Principal investigator: dr Katarzyna Piekarowicz

    Uniwersytet Wrocławski, Wydział Biotechnologii

  4. Novel insights into hydrogen sulfide-mediated cytoprotection - can H2S prevent the progression of Duchenne muscular dyst...

    Call: OPUS 18 , Panel: NZ3

    Principal investigator: dr hab. Agnieszka Łoboda

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  5. Molecular and cellular mechanisms of pro-regenerative activity of stem cell- derived extracellular vesicles (EVs) in isc...

    Call: MAESTRO 11 , Panel: NZ3

    Principal investigator: dr hab. Ewa Zuba-Surma

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  6. Impaired angiogenesis in Duchenne muscular dystrophy - is there a role for heme oxygenase-1 and statins?

    Call: OPUS 11 , Panel: NZ1

    Principal investigator: dr hab. Agnieszka Łoboda

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  7. Embryotoxicity and teratogenicity as a result of response to DNA damage in iPS cells: the effect of methylmercury chlori...

    Call: PRELUDIUM 9 , Panel: NZ7

    Principal investigator: Justyna Augustyniak

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN